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Copyright © 2009 AHC Reversion-induced LIM protein (RIL) is a member of the ALP (actinin-associated LIM pro-
tein) subfamily of the PDZ/LIM protein family. RIL serves as an adaptor protein and seems
to regulate cytoskeletons. Immunoblotting suggested that RIL is concentrated in the astro-
cytes in the central nervous system. We then examined the expression and localization of
RIL in the rat central nervous system and compared it with that of water channel aquaporin
4 (AQP4). RIL was concentrated in the cells of ependyma lining the ventricles in the brain
and the central canal in the spinal cord. In most parts of the central nervous system, RIL
was expressed in the astrocytes that expressed AQP4. Double-labeling studies showed that
RIL was concentrated in the cytoplasm of astrocytes where glial fibrillary acidic protein was
enriched as well as in the AQP4-enriched regions such as the endfeet or glia limitans. RIL
was also present in some neurons such as Purkinje cells in the cerebellum and some
neurons in the brain stem. Differential expression of RIL suggests that it may be involved
in the regulation of the central nervous system.
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I. Introduction
Reversion-induced LIM protein (RIL) is a member of
the ALP (actinin-associated LIM protein) subfamily of the
PDZ/LIM protein family, and has a PDZ domain in the N-
terminus and a LIM domain in the C-terminus [for review
see 15]. RIL was identified as one of LIM-domain proteins
whose expression was down-regulated in transformed cells,
and hence was considered to play a role in the control of cel-
lular proliferation as a negative growth regulator [6]. In fact,
expression of RIL was found down-regulated in prostate
cancer [18]. Silencing or low level of expression of RIL in
cancer cells was attributed to deletion or promoter methyla-
tion [2].
Through PDZ and LIM domains, RIL is considered to
interact with many proteins. By binding to alpha-actinin
through its PDZ domain, RIL interacts with actin cytoskele-
ton, and regulates stress fiber turnover [17]. RIL serves as an
adaptor protein by binding to the AMPA glutamate receptor
subunit GluR-A C-terminal peptide through its LIM domain
and alpha-actinin via its PDZ domain [11]. By linking
AMPA receptors to the actin cytoskeleton, RIL seems to
regulate the dendritic transport of AMPA receptors in neu-
ronal cells. RIL also serves in the anchoring of signaling
molecules such as protein tyrosine phosphatase through its
LIM domain [3] and C-terminus [19].
AQP4 is a member of water channel protein, aquaporin
(AQPs) [13]. In the central nervous system, AQP4 is mainly
expressed in astrocytes. AQP4 is concentrated in theIida et al. 10
perivascular endfeet surrounding blood vessels, and regu-
lates the water transfer in the blood-brain barrier [13].
Concentration to the endfeet seems to be due to the binding
to the PDZ domain of a scaffolding adaptor protein alpha-
syntrophin [8]. AQP4 in astrocytes was also shown to be
closely associated with the F-actin cytoskeleton [9, 10].
Northern blot analysis showed that RIL is expressed in
a variety of tissues in the rat [6]. In situ hybridization in
mouse tissues revealed that RIL expression was evident in
the brain and certain epithelia. Preliminary immunofluores-
cence examination showed localization of RIL in epithelial
cells in the mouse lung, stomach, and skin [3]. However,
precise immunohistochemical localization of RIL protein
has yet to be documented. In this work, we show the local-
ization of RIL in the rat central nervous system and com-
pared it with that of AQP4 [13].
II. Materials and Methods
Antibodies
Primary antibodies used were as follows: affinity-
purified rabbit anti-AQP4 antibody [7]; goat anti-RIL
antibody raised against C-terminal amino acids of rat RIL
(Abcam, Cambridge, UK); mouse anti-glial fibrillary acidic
protein (GFAP) monoclonal antibody (Millipore, Billerica,
MA). Secondary antibodies used were as follows: Alexa
488-labeled donkey anti-goat IgG (Invitrogen, Carlsbad,
CA, USA); Rhodamine Red X-labeled donkey anti-rabbit
IgG (Jackson Immunoresearch); Rhodamine Red X-labeled
donkey anti-mouse IgG (Jackson Immunoresearch).
Animals and tissue preparation
Male Wistar rats, 4 weeks of age, were used except
otherwise stated. The protocol followed in this study was
approved by the Animal Care and Experimentation
Committee, Gunma University. For immunofluorescence
histochemistry, rats were anesthetized by an intraperitoneal
injection of sodium pentobarbital. They were perfused from
the left ventricle with phosphate-buffered saline (PBS) fol-
lowed by 3% paraformaldehyde in PBS. Specimens of the
brain and spinal cord were removed, cut into slices of 3–5
mm thick, and further fixed in the same fixative overnight at
4°C. They were washed with PBS and immersed in a graded
series of sucrose in PBS up to 20%. Samples were embedded
in OCT compound (Sakura Finetechnical, Tokyo, Japan),
rapidly frozen with liquid nitrogen, and stored at –80°C until
use. Cryostat sections, 8–10-µm thick, were cut with a Leica
CM 1900 cryostat (Vienna, Austria), mounted on MAS-
coated glass slides (Matsunami, Osaka, Japan), air-dried,
and used for immunofluorescent labeling.
Immunoblotting
Cortical astrocytes were prepared from postnatal cere-
bral cortices of Wistar rats (P1) and cultured as described
previously [5]. Homogenate from the primary culture of
astrocytes and the brain from adult female Wistar rats were
homogenized and processed for immunoblotting according
to the standard procedure as described [5].
Immunofluorescent staining
Immunofluorescent staining was carried out basically
as previously described [1, 10]. Sections were washed three
times in PBS for 15 min, and were then incubated with 2%
bovine serum albumin (BSA) in PBS for 1 hr. Sections were
first incubated with goat anti-RIL antibody overnight at 4°C,
washed with PBS, and incubated with Alexa 488-labeled
donkey anti-goat IgG for 1 hr at room temperature. For
AQP4 labeling, specimens were further incubated with
rabbit anti-AQP4 antibody for 1 hr at room temperature
and Rhodamine Red X-labeled donkey anti-rabbit IgG. For
astrocyte labeling, specimens were incubated with mouse
anti-GFAP antibody for 1 hr at room temperature followed
by incubation with Rhodamine Red X-labeled donkey anti-
mouse IgG. Nuclear staining was performed by adding
DAPI (4',6 diamidino-2-phenylindole) (Roche Diagnostics,
Basel, Switzerland) [12]. After immunolabeling, sections
were mounted as described [1]. They were examined with
an Olympus BX-60 epifluorescence microscope (Tokyo,
Japan) and images were recorded with a CoolSNAP K4
cooled CCD camera (Nippon Roper, Tokyo, Japan).
III. Results
Homogenates from the rat brain and cultured astrocytes
were subjected to immunoblotting with antibodies to RIL. A
37-kDa-band, which is within the range of the predicted
molecular weight of RIL (35.5 kDa) [11], was detected in
both specimens, showing that RIL protein is expressed in
these specimens (Fig. 1). In addition, a strong band in cul-
tured astrocytes suggested that RIL might be concentrated
in the astrocytes. These results demonstrated the specificity
of the anti-RIL antibody and the presence of RIL protein in
the brain.
We next examined the localization of RIL in the rat
central nervous system by immunofluorescent labeling. In
positive cells, labeling for RIL was mostly confined to the
cytoplasm. In the cerebrum, RIL was concentrated along the
ependyma (Fig. 2a). RIL was also rich in star-shaped cells.
Double-labeling with astrocyte marker GFAP revealed that
RIL was colocalized with GFAP, showing that RIL is ex-
pressed in the astrocytes (Fig. 2a, b). AQP4 is concentrated
in the endfeet surrounding the blood vessels and the glia lim-
itans of astrocytes [13]. Double-labeling studies showed that
RIL was concentrated in the cytoplasm of astrocytes where
GFAP was enriched as well as in the AQP4-enriched regions
such as the endfeet or glia limitans (Fig. 2c). In the dien-
cephalon, RIL was enriched in the epedymal cells lining the
third ventricular wall as in other parts of the brain (Fig. 3).
Double-labeling with AQP4 revealed that RIL was rich in
blood vessels in the side wall of the third ventricle, but was
scarce in those in the roof region (Fig. 3).
In the cerebellum, RIL was found in Purkinje cells and
cells in the granular layer (Fig. 4). Molecular layers were
weakly labeled, but no labeling in the medulla, showing thatLocalization of RIL in Rat CNS 11
oligodendrocytes did not express RIL. In the brain stem, RIL
was highly concentrated in the epedymal cells lining the
fourth ventricle (Fig. 5a). RIL was also found in the blood
vessels. Some of neurons were strongly positive for RIL
(Fig. 5b). The astrocytes were rarely labeled for RIL in this
region. In the spinal cord, RIL was also highly concentrated
in the epedymal cells lining the central canal (Fig. 6b). In
addition, the astrocytes were positive for RIL (Fig. 6a).
The expression of RIL in the central nervous system is
summarized in Table 1.
IV. Discussion
We show in this work that the RIL protein is present in
the rat brain by immunoblotting. This observation is in ac-
cord with the results of the Northern blot analysis that RIL is
expressed in a variety of organs including the brain [6].
Some of the Purkinje cells in the cerebellum were positive
for RIL. In situ hybridization revealed that mRNA for RIL
was detected in subgroups of neurons including Purkinje
cells in the rat brain [6]. Although all of the Purkinje cells
were shown to have similar levels of RIL mRNA [6], we
found the level of RIL protein varied from one Purkinje cell
to another. The regulatory mechanism in the translation of
Fig. 2. Immunofluorescence localization of RIL, GFAP, and AQP4 in the fimbria of hippocampus. Nuclei were stained with DAPI (blue).
*: choroid plexus in the lateral ventricle. (a, b) Double-labeling for RIL (a) and GFAP (b) shows that RIL is concentrated in astrocytes
marked with GFAP labeling (arrows). (c) Double-labeling for RIL (green) and AQP4 (red) shows that RIL is present in blood vessels as well
(arrows). Bars=50 µm.
Fig. 1. Immunoblotting of astrocytes and brain with antibodies to
RIL. Twenty micrograms of cultured astrocytes (a) and rat brain (b)
homogenates were subjected to immunoblotting. Positions of
molecular size markers (kDa) are shown to the left of the blot.Iida et al. 12
RIL mRNA and/or RIL protein turnover may be responsible
for the difference between the mRNA level and protein
level. In the brain stem, some of the neurons were strongly
positive for RIL as well. Differential expression of RIL
might contribute to the differential regulation of neurons.
Abundant RIL was detected in the primary culture of
rat astrocytes. Double immunofluorescence microscopy
with GFAP revealed the expression of RIL in the astrocytes
in the brain and spinal cord. Double-labeling with AQP4
also confirmed the expression of RIL in astrocytes. Expres-
sion level of RIL was not uniform in the central nervous sys-
tem as in neurons. RIL was not detected in astrocytes in the
brain stem. The significance of the differential expression of
Fig. 3. Immunofluorescence localization of RIL (green) and AQP4
(red) in the third ventricle (*). Large arrows show blood vessels
positive for RIL and AQP4. A small arrow indicates an AQP4-
positive and RIL-negative blood vessel. Nuclei were stained
with DAPI (blue). Bar=50 µm.
Fig. 4. Immunofluorescence localization of RIL (green) and AQP4
(red) in the cerebellum. Nuclei were stained with DAPI (blue).
RIL is present in some of Purkinje cells (arrow). Me: medulla.
Bar=50 µm.
Fig. 5. Immunofluorescence localization of RIL (green) and GFAP
(red) in the brain stem. Nuclei were stained with DAPI (blue).
(a) RIL is concentrated in the ependyma and blood vessels
(arrows). *: fourth ventricle. (b) RIL is abundant in some of
neurons in the brain stem (arrows). Bars=50 µm.Localization of RIL in Rat CNS 13
RIL in astrocytes remains to be clarified.
In adult mouse tissues, RIL mRNA was detected in var-
ious epithelia, such as in the uterus and lung by in situ hy-
bridization [6]. RIL protein was also found in the epithelia of
the lung, stomach, and skin [3]. In the central nervous sys-
tem, we found that the ependymal cells lining the ventricles
in the brain and central canal in the spinal cord were positive
for RIL by immunofluorescence microscopy, with stronger
expression in the spinal cord and the brain stem. RIL in these
epithelia may contribute to the shaping and organization of
polarized epithelial cells by modulating actin cytoskeleton
with its PDZ domain [3].
Since RIL binds to the cytoskeletal elements via its
PDZ domain through alpha-actinin, RIL may be involved in
the regulation of cytoskeletal organization in the central ner-
vous system. RIL was proposed to play an important role in
the transport of AMPA receptors in neurons [12]. In astro-
cytes, concentration of AQP4 to glia limitans and perivascu-
lar process is modulated by actin cytoskeleton [10]. Since
actin cytoskeleton is important in regulating the localization
and trafficking of water channels AQP2 in renal collecting
duct cells [14], RIL may play a role in the localization of
AQP4 in astrocytes by regulating their actin cytoskeleton.
CLP-36 (C-terminal LIM domain protein 36), another
member of PDZ/LIM protein family, is expressed in nervous
tissues in addition to RIL [16]. CLP-36 was also suggested
to serve as adaptors to the cytoskeleton via alpha-actinin in
non-muscle cells [16]. We used polyclonal antibodies raised
against C-terminal 14 peptides of rat RIL in the present
study. Although C-terminal amino acids of rat CLP-36 is
distinct from that of rat RIL, it has an identical 3-amino-acid
sequence. Therefore, we cannot exclude the possibility that
we detected CLP-36 in addition to RIL. Further study is
needed to clarify this point.
Although the exact function of RIL remains to be clari-
fied, RIL seems to be involved in cellular growth and differ-
entiation [4, 6, 13]. Differential expression levels in neurons,
astrocytes, and blood vessel walls (Table 1) suggest that RIL
might reflect the levels of differentiation and growth among
them.
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